UBS Reiterates Buy Rating on The Dow Chemical Company on Conservative Outlook
In a report published Friday, UBS Investment Research analyst John Roberts reiterated a Buy rating on The Dow Chemical Company (NYSE: DOW).
In the report, UBS Investment Research noted, “We estimate DOW's sales are ~80% petroleum-based, split between oil- & gas-based raws. Gas-based chemical producers could enjoy near-peak cash flow for a while; oil-based ones should recover the most as demand improves. We believe KRA could transition from being viewed as a basic to a specialty chemical firm...We (and we believe, consensus) may have conservative outlooks for DOW and KRA, as both faced major headwinds recently (both have 2/3 of sales ex-N. Am.). Comps in Europe & Asia should become increasingly easy. For KRA, normal weather next year should provide easy comps for paving & roofing (30% of sales).”
The Dow Chemical Company closed on Wednesday at $32.50.
Latest Ratings for DOW
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2022 | Goldman Sachs | Maintains | Neutral | |
Jan 2022 | Goldman Sachs | Maintains | Neutral | |
Jan 2022 | Mizuho | Maintains | Neutral |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: John Roberts UBS Investment ResearchAnalyst Color Reiteration Analyst Ratings